Shanghai Medicilon Inc Net Asset Quality Index
Shanghai Medicilon Inc net asset quality index. Shanghai Medicilon Inc (688202) has a Net Asset Quality Index of 69.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.88 Billion minus total liabilities of CN¥878.17 Million yields net assets of CN¥2.00 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Shanghai Medicilon Inc book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shanghai Medicilon Inc (2016–2025)
Net asset quality index of Shanghai Medicilon Inc from 2016 to 2025. This chart shows how Shanghai Medicilon Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 69.5%, representing net assets of CN¥2.00 Billion against total assets of CN¥2.88 Billion CNY. Check Shanghai Medicilon Inc (688202) strategic investment index to assess the company's strategic physical and investment asset allocation.
Shanghai Medicilon Inc Net Asset Quality Index by Year (2016–2025)
Shanghai Medicilon Inc net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shanghai Medicilon Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shanghai Medicilon Inc market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.8% | CN¥1.93 Billion | CN¥2.62 Billion | CN¥687.85 Million | ▼ -2.0 pp |
| 2024 | 75.8% | CN¥2.14 Billion | CN¥2.82 Billion | CN¥683.10 Million | ▼ -1.1 pp |
| 2023 | 76.9% | CN¥2.51 Billion | CN¥3.27 Billion | CN¥755.07 Million | ▲ +8.1 pp |
| 2022 | 68.8% | CN¥1.60 Billion | CN¥2.33 Billion | CN¥726.80 Million | ▼ -5.2 pp |
| 2021 | 74.0% | CN¥1.33 Billion | CN¥1.79 Billion | CN¥466.06 Million | ▼ -9.2 pp |
| 2020 | 83.2% | CN¥1.14 Billion | CN¥1.36 Billion | CN¥228.67 Million | ▼ -5.4 pp |
| 2019 | 88.7% | CN¥1.00 Billion | CN¥1.13 Billion | CN¥127.73 Million | ▲ +15.1 pp |
| 2018 | 73.6% | CN¥347.89 Million | CN¥472.95 Million | CN¥125.06 Million | ▼ -0.2 pp |
| 2017 | 73.7% | CN¥287.32 Million | CN¥389.61 Million | CN¥102.29 Million | ▲ +2.4 pp |
| 2016 | 71.4% | CN¥246.09 Million | CN¥344.90 Million | CN¥98.81 Million | — |